Christina Mehriary
Family Medicine · Sarasota, FLNPI 1699812057
Payments from drug & device makers
Across 86 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$264
- Cardiovascular Systems Inc.$190
- Novo Nordisk$148
- Pfizer$145
- Exact Sciences$121
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$101
- plus $517 from 16 others
What the payments were for
- Food & beverage$1,47199%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $264 |
| Cardiovascular Systems Inc. | 3 | $190 |
| Novo Nordisk | 8 | $148 |
| Pfizer | 13 | $145 |
| Exact Sciences | 4 | $121 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $101 |
| AstraZeneca | 5 | $70 |
| Antares Pharma, Inc. | 4 | $57 |
| Heartflow, Inc. | 1 | $51 |
| AbbVie | 4 | $48 |
| Boehringer Ingelheim | 3 | $48 |
| Merck | 3 | $41 |
| Novartis | 2 | $35 |
| Johnson & Johnson | 2 | $34 |
| GE HealthCare | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $12 |
How this compares
$1,486 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $56,739 |
| FarxigaDapagliflozin Propanediol | 33 | $41,662 |
| JanuviaSitagliptin Phosphate | 27 | $32,085 |
| JardianceEmpagliflozin | 21 | $28,658 |
| OzempicSemaglutide | 21 | $27,587 |
| XareltoRivaroxaban | 18 | $27,335 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 81 | $17,576 |
| Repatha SureclickEvolocumab | 18 | $13,311 |
| Spiriva HandihalerTiotropium Bromide | 22 | $12,570 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 26 | $7,445 |
| Atrovent HfaIpratropium Bromide | 13 | $7,103 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $7,003 |
| Wixela InhubFluticasone Propion/Salmeterol | 33 | $6,277 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $5,546 |
| LantusInsulin Glargine,hum.Rec.Anlog | 36 | $4,749 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $145 | $56,73944 claims |
| AstraZenecaFarxiga | $70 | $41,66233 claims |
| MerckJanuvia | $41 | $32,08527 claims |
| Boehringer IngelheimJardiance | $48 | $28,65821 claims |
| Novo NordiskOzempic | $148 | $27,58721 claims |
| Johnson & JohnsonXarelto | $34 | $27,33518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Sarasota
- Niaz AusafSarasota$3.8M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.